[
  {
    "ts": null,
    "headline": "UnitedHealth Group (UNH) Dips More Than Broader Market: What You Should Know",
    "summary": "In the latest trading session, UnitedHealth Group (UNH) closed at $345.56, marking a -1.78% move from the previous day.",
    "url": "https://finnhub.io/api/news?id=6512362634c685745906adc20d1a734ec62bdcf1044aae73e3140e0e40345c66",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758836703,
      "headline": "UnitedHealth Group (UNH) Dips More Than Broader Market: What You Should Know",
      "id": 136888316,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "In the latest trading session, UnitedHealth Group (UNH) closed at $345.56, marking a -1.78% move from the previous day.",
      "url": "https://finnhub.io/api/news?id=6512362634c685745906adc20d1a734ec62bdcf1044aae73e3140e0e40345c66"
    }
  },
  {
    "ts": null,
    "headline": "Warren Buffett Just Dumped the Last of His BYD Stock. Should You Give Up, Too?",
    "summary": "After 17 years, Berkshire Hathaway has exited its position in BYD.",
    "url": "https://finnhub.io/api/news?id=ef800249ccd992af15d6077e60ac32b550d6f03acc4f352c8b22305233703098",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758830816,
      "headline": "Warren Buffett Just Dumped the Last of His BYD Stock. Should You Give Up, Too?",
      "id": 136888317,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "After 17 years, Berkshire Hathaway has exited its position in BYD.",
      "url": "https://finnhub.io/api/news?id=ef800249ccd992af15d6077e60ac32b550d6f03acc4f352c8b22305233703098"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Group (UNH) Slid Due to Decline in Investor Confidence",
    "summary": "PGIM, an investment management company, released its “PGIM Jennison Health Sciences Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities in the second quarter of 2025 experienced significant volatility, as the steep sell-off that initiated at the beginning of the quarter ultimately led to a strong recovery. The S&P […]",
    "url": "https://finnhub.io/api/news?id=bef193b88e79d6fffca161878639ff842f2d26152c7e1e0f4c5c59101471cbbf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758808692,
      "headline": "UnitedHealth Group (UNH) Slid Due to Decline in Investor Confidence",
      "id": 136883023,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "PGIM, an investment management company, released its “PGIM Jennison Health Sciences Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities in the second quarter of 2025 experienced significant volatility, as the steep sell-off that initiated at the beginning of the quarter ultimately led to a strong recovery. The S&P […]",
      "url": "https://finnhub.io/api/news?id=bef193b88e79d6fffca161878639ff842f2d26152c7e1e0f4c5c59101471cbbf"
    }
  },
  {
    "ts": null,
    "headline": "Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit",
    "summary": "CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with UnitedHealthcare insurance company, a unit of UnitedHealth Group Inc. (NYSE: UNH). Effective September 15, the agreement covers over 51 million people throughout the United States, providing the CNSide Cerebrospinal Fluid (CSF) Tumor Cell Enumeration laboratory developed test (LDT). The CNSide CSF Assay Platform supports rapid diagnoses, treatment monitoring, and treatmen",
    "url": "https://finnhub.io/api/news?id=b9910ee42554bc70f5e330a4a8307d49969965d7e64d01e695fac31f4f6f022a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758799869,
      "headline": "Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit",
      "id": 136883024,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with UnitedHealthcare insurance company, a unit of UnitedHealth Group Inc. (NYSE: UNH). Effective September 15, the agreement covers over 51 million people throughout the United States, providing the CNSide Cerebrospinal Fluid (CSF) Tumor Cell Enumeration laboratory developed test (LDT). The CNSide CSF Assay Platform supports rapid diagnoses, treatment monitoring, and treatmen",
      "url": "https://finnhub.io/api/news?id=b9910ee42554bc70f5e330a4a8307d49969965d7e64d01e695fac31f4f6f022a"
    }
  },
  {
    "ts": null,
    "headline": "Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer",
    "summary": "HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a national agreement with UnitedHealthcare Insurance Company (NYSE: UNH), effective September 15, 2025, covering over 51 million people throughout the United States, to provide the CNSide® Cerebrospinal Fluid Tumor Cell Enumeration laboratory developed test (LDT). The CNSide® CSF Assay Platform suppo",
    "url": "https://finnhub.io/api/news?id=49d7c513713acaa10b1b9a1c6b4fc1038a881a6f110a453c9bacee02e692e44e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758799800,
      "headline": "Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer",
      "id": 136883025,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a national agreement with UnitedHealthcare Insurance Company (NYSE: UNH), effective September 15, 2025, covering over 51 million people throughout the United States, to provide the CNSide® Cerebrospinal Fluid Tumor Cell Enumeration laboratory developed test (LDT). The CNSide® CSF Assay Platform suppo",
      "url": "https://finnhub.io/api/news?id=49d7c513713acaa10b1b9a1c6b4fc1038a881a6f110a453c9bacee02e692e44e"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth, Caterpillar share losses contribute to Dow's nearly 200-point fall",
    "summary": "UnitedHealth, Caterpillar share losses contribute to Dow's nearly 200-point fall",
    "url": "https://finnhub.io/api/news?id=506e0d4093cce0746b92ce54502b9f9fcbd3f497373c5865df54525f2f84aa1b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758793500,
      "headline": "UnitedHealth, Caterpillar share losses contribute to Dow's nearly 200-point fall",
      "id": 136921566,
      "image": "",
      "related": "UNH",
      "source": "MarketWatch",
      "summary": "UnitedHealth, Caterpillar share losses contribute to Dow's nearly 200-point fall",
      "url": "https://finnhub.io/api/news?id=506e0d4093cce0746b92ce54502b9f9fcbd3f497373c5865df54525f2f84aa1b"
    }
  },
  {
    "ts": null,
    "headline": "BUZZ Investing: Stocks Move Higher On Fed Cut Hopes",
    "summary": "Institutional buying and AI momentum fueled BUZZ Index gains, with UnitedHealth and Nebius leading on strong earnings, contracts, and sentiment. Read more here.",
    "url": "https://finnhub.io/api/news?id=54e5c27195620048460c28be02f171bf11d4401cbf30d50298162c471b33da00",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758792600,
      "headline": "BUZZ Investing: Stocks Move Higher On Fed Cut Hopes",
      "id": 136882278,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/482730527/image_482730527.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "Institutional buying and AI momentum fueled BUZZ Index gains, with UnitedHealth and Nebius leading on strong earnings, contracts, and sentiment. Read more here.",
      "url": "https://finnhub.io/api/news?id=54e5c27195620048460c28be02f171bf11d4401cbf30d50298162c471b33da00"
    }
  }
]